Evidence map›Paper›PMID 29487953›Full record

ArticleDiabetologia2018

FAM13A and POM121C are candidate genes for fasting insulin: functional follow-up analysis of a genome-wide association study.

Veroniqa Lundbäck, Agne Kulyte, Rona J Strawbridge, Mikael Ryden, Peter Arner, Claude Marcus, Ingrid Dahlman

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The Influence ofGenes · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Increasing fasting glucose and fasting insulin associated with elevated bone mineral density-evidence from cross-sectional and MR studies.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Article
  18. Review
  19. Review
  20. Transglutaminases and Obesity in Humans: Association ofInternational journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Veroniqa LundbäckDepartment of Clinical Science, Intervention and Technology, Division of Paediatrics, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Agne KulyteDepartment of Medicine, Huddinge, Karolinska Institutet, C2:94, SE-141 86, Stockholm, Sweden.
Rona J StrawbridgeInstitute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Mikael RydenDepartment of Medicine, Huddinge, Karolinska Institutet, C2:94, SE-141 86, Stockholm, Sweden.
Peter ArnerDepartment of Medicine, Huddinge, Karolinska Institutet, C2:94, SE-141 86, Stockholm, Sweden.
Claude MarcusDepartment of Clinical Science, Intervention and Technology, Division of Paediatrics, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Ingrid DahlmanDepartment of Medicine, Huddinge, Karolinska Institutet, C2:94, SE-141 86, Stockholm, Sweden. ingrid.dahlman@ki.se.
Karolinska Institutet · SEUniversity of Glasgow · GB

Funding

Medical Research Council MR/S003061/1
6 · The paper itself

Abstract

aims/hypothesisBy genome-wide association meta-analysis, 17 genetic loci associated with fasting serum insulin (FSI), a marker of systemic insulin resistance, have been identified. To define potential culprit genes in these loci, in a cross-sectional study we analysed white adipose tissue (WAT) expression of 120 genes in these loci in relation to systemic and adipose tissue variables, and functionally evaluated genes demonstrating genotype-specific expression in WAT (eQTLs).

methodsAbdominal subcutaneous adipose tissue biopsies were obtained from 114 women. Basal lipolytic activity was measured as glycerol release from adipose tissue explants. Adipocytes were isolated and insulin-stimulated incorporation of radiolabelled glucose into lipids was used to quantify adipocyte insulin sensitivity. Small interfering RNA-mediated knockout in human mesenchymal stem cells was used for functional evaluation of genes.

resultsAdipose expression of 48 of the studied candidate genes associated significantly with FSI, whereas expression of 24, 17 and 2 genes, respectively, associated with adipocyte insulin sensitivity, lipolysis and/or WAT morphology (i.e. fat cell size relative to total body fat mass). Four genetic loci contained eQTLs. In one chromosome 4 locus (rs3822072), the FSI-increasing allele associated with lower FAM13A expression and FAM13A expression associated with a beneficial metabolic profile including decreased WAT lipolysis (regression coefficient, R = -0.50, p = 5.6 × 10 CONCLUSIONS/

interpretationGene expression and adipocyte functional studies support the notion that FAM13A and POM121C control adipocyte lipolysis and adipogenesis, respectively, and might thereby be involved in genetic control of systemic insulin sensitivity.

Indexed as

Genome-Wide Association StudyAdipocytesAdipogenesisAdipose TissueAdiposityAdultFastingFemaleFollow-Up StudiesGenotypeGlucoseGTPase-Activating ProteinsHumansInsulinInsulin ResistanceLipolysisFAM13A protein, humanGlucoseGTPase-Activating ProteinsInsulinMembrane GlycoproteinsPOM121 protein, humanGenomicsInsulin sensitivityLipid metabolism

Identifiers

PMID29487953
PMCPMC6448992
OpenAlexW2789481407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.